Skip to content

Evaluation of a Venous-Return Assist Device (Venowave) to Treat Post-Thrombotic Syndrome: A Randomized Controlled Trial

Evaluation of a Venous-Return Assist Device (Venowave) to Treat Post-Thrombotic Syndrome: A Randomized Controlled Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00182208
Enrollment
32
Registered
2005-09-16
Start date
2004-05-31
Completion date
2005-12-31
Last updated
2008-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postphlebitic Syndrome

Keywords

PTS, Post phlebitic Syndrome, Activities of Daily Living, Quality of Life

Brief summary

The purpose of this study is to determine whether daily use of a lower limb venous-return assist device, Venowave', improves leg symptoms, ability to perform activities of daily living, and quality of life in subjects with severe PTS.

Detailed description

Eligible consenting patients will be randomly allocated to receive either the veno-device (active or placebo for 8 weeks and crossed over for a further 8 weeks (active or placebo) following a 4 week 'wash out' period.( A randomized controlled 'crossover' study}

Interventions

DEVICEVeno-device (Venowave)

Sponsors

Health Canada
CollaboratorOTHER_GOV
Hamilton Health Sciences Corporation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Past History of objectively documented deep vein thrombosis * Daily leg swelling with discomfort (i.e. report at least one of the following symptoms: heavy legs, aching legs and/or throbbing) for a minimum of 6 months * Over 18 years of age (and of either gender). * Villalta score of greater than 14(i.e.severe post phlebitic syndrome)

Exclusion criteria

* Episode of objectively documented deep vein thrombosis occurred less than 6 months before recruitment * Subjects report that their symptoms have been unstable (worsening, improving or variable over the previous month). * Active venous ulceration * Baseline leg circumference greater than 50 cm (cuff will not fit subject) * Symptomatic peripheral arterial disease Peripheral neuropathy

Design outcomes

Primary

MeasureTime frame
Clinical Success measured with the Global Rating Instrument

Secondary

MeasureTime frame
PTS-CCS questionnaire
Villalta Scale
Veines Quality of Life Questionnaire

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 5, 2026